Implementation of a novel home delivery service during pandemic.
Eur J Hosp Pharm
; 28(Suppl 2): e120-e123, 2021 11.
Article
in English
| MEDLINE | ID: covidwho-1575275
ABSTRACT
INTRODUCTION:
During the COVID-19 pandemic, measures have been put in place to adapt to patients' needs during home quarantine, such as "telehealthcare". With this service, hospital pharmacists develop a distinct role via the implementation of pharmacovigilance services and pharmaceutical care plans for patients with comorbidities, and for special populations as immunosuppressed patients.MethodsCross-sectional study involving hospital and community pharmacists actively practising during the COVID-19 pandemic. Patients who could not come to the hospital pharmacy department were provided with a delivery service to the community pharmacy of their choice.RESULTS:
A total of 1186 patients requested this service. Erythropoiesis-stimulating agents were the most in-demand medication, followed by rheumatoid arthritis and antiretroviral drugs. 125 patients responded to the telephone survey, most of whom stated that they would use the delivery service again, and expressed their desire to continue doing so.DISCUSSION:
Without a doubt, telepharmacy and medication delivery services have provided multiple benefits during home quarantine. The delivery service enabled us to provide drugs to patients in their immediate environment through a service that was free for both the patient and the hospital pharmacy service. However, at present, the available evidence of the impact of telepharmacy models is sparse.CONCLUSIONS:
This medication delivery service has provided multiple benefits to patients during home quarantine. Although the users of this service seem to be satisfied with the current model, in the future, we should consider which patients would benefit most from this service and shape it to individual needs.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pharmacy Service, Hospital
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Eur J Hosp Pharm
Year:
2021
Document Type:
Article
Affiliation country:
Ejhpharm-2020-002500
Similar
MEDLINE
...
LILACS
LIS